GRI BIO INC (GRI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.88+25.76%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GRI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | — | — | — | 0.0 | 0.1 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 4.1 | 6.8 | 3.8 | 3.2 | 0.2 | 5.2 | 3.7 |
| Operating Income | (9.7) | (12.0) | (8.2) | (11.4) | (2.2) | (9.3) | (4.8) |
| Earnings from Continuing Operations | |||||||
| Income Tax Expense | — | 0.0 | — | — | — | — | — |
| Net Income | |||||||
| Net Income | (9.7) | (12.0) | (8.2) | (13.0) | (3.2) | (9.3) | (4.8) |
| Per Share | |||||||
| Basic EPS | (5.35) | (121.80) | (55.21) | — | (24.95) | (1.42) | (1.07) |
| Diluted EPS | (5.35) | (121.80) | (55.21) | — | (24.95) | (1.42) | (1.07) |
| Basic Weighted Avg Shares | 1.8 | 0.1 | 0.2 | 0.0 | 0.1 | 6.5 | 4.5 |
| Diluted Weighted Avg Shares | 1.8 | 0.1 | 0.2 | 0.0 | 0.1 | 6.5 | 4.5 |
| Supplemental | |||||||
| EBIT | (9.7) | (12.0) | (8.2) | (11.4) | (2.2) | (9.3) | (4.8) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.